We also explored drugs that potentially respond to overexpression of PIMREG in BC, as they might offer novel immunological perspectives to understand the mechanism of tumor progression and provide useful evidence for future studies regarding the immunological and pharmacological therapies for BC patients. The gene discussed is PIMREG; the disease is breast cancer.